Rayonier Advanced Materials Inc.
$4.61-$0.28 (-5.7%)
Last close · Data as of Nov 20, 2026
- Market cap
- $576.6M
- P/E
- -1.4x
- EV / EBITDA
- 9.4x
- Revenue
- $1.5B
- Net margin
- -28.8%
- ROCE
- 0.8%
Price chart
Technical chartScreen technicals →-18.7% over the last year
Daily closes.
Go deeper
Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes
Performance
Price return, before dividends, to the 20 Nov 2026 close.
- 1M
- -34.1%
- 3M
- -46.3%
- 6M
- -45.7%
- 1Y
- -18.7%
- 5Y
- -22.3%
52-week range
Day change -$0.28 (-5.7%) from $4.89 to $4.61 · Last close Nov 20, 2026
Best weekday to invest, historically
The same weekly amount in RYAM, bought on each weekday since 2021.
News & filings
What Rayonier Advanced Materials filed, who traded, and what's next
How to read this
"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.
AI Summary
US StockConcernThe company made a net loss of 422 million US dollars in fiscal 2025.
Strengths
No strength stands out for this company on the data on file.
Prices to the 20 Nov 2026 close · Financial year: fiscal 2025
Rule-based from financial data. Not advice.
About the company
Rayonier Advanced Materials Inc. manufactures and sells cellulose specialty products in the United States, China, Europe, Japan, rest of Asia, Canada, Latin America, and internationally. It operates through Cellulose Specialties, Biomaterials, Cellulose Commodities, Paperboard, and High-Yield Pulp.
Read moreShow less
Rayonier Advanced Materials Inc. manufactures and sells cellulose specialty products in the United States, China, Europe, Japan, rest of Asia, Canada, Latin America, and internationally. It operates through Cellulose Specialties, Biomaterials, Cellulose Commodities, Paperboard, and High-Yield Pulp. The company's products include cellulose specialties, which are natural polymers that are used as raw materials to manufacture a range of consumer-oriented products, such as liquid crystal displays, impact-resistant plastics, thickeners for food products, pharmaceuticals, cosmetics, cigarette filters, high-tenacity rayon tire cords and industrial hoses, food casings, paints, lacquers, munitions, and explosives; and biomaterials, including biofuels, lignosulfonates, prebiotics, tall oil soap, and HCE and turpentine. It also offers commodity products, such as commodity viscose used in woven applications, including rayon textiles for clothing and other fabrics, as well as in non-woven applications comprising baby wipes, cosmetic and personal wipes, industrial wipes, and mattress ticking; and absorbent materials consisting of fluff that are used as an absorbent medium in disposable baby diapers, feminine hygiene products, incontinence pads, convalescent bed pads, industrial towels and wipes, and non-woven fabrics. In addition, the company provides paperboards for packaging, printing documents, brochures, promotional materials, paperback books and catalog covers, file folders, freezer, tags, and lottery tickets; and high-yield pulps to produce hardwood aspen, maple, and birch species for paperboard, packaging, printing and writing papers, and various other paper products. Rayonier Advanced Materials Inc. was founded in 1926 and is headquartered in Jacksonville, Florida.
- Sector
- Basic Materials
- Shares outstanding
- 67.0M
Key statistics
Screen fundamentals →Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.
Valuation
- Market cap
- $576.6M
- P/E
- -1.4x
- P/B
- 1.8x
- EV / EBITDA
- 9.4x
- EV / Sales
- 0.9x
- P/S
- 0.4x
- 52-week high
- $11.75
- 52-week low
- $4.61
Profitability
- Operating margin
- 0.8%
- Net margin
- -28.8%
- EBITDA margin
- 9.3%
- ROE
- -133.5%
- ROCE
- 0.8%
- ROIC
- 0.2%
- ROA
- -24.0%
- Asset turnover
- 0.83
Growth
- RevenueFY2025, the latest fiscal year in the company's growth history.
- $1.5B
- Revenue growth, 1YFY2025, the latest fiscal year in the company's growth history.
- -10.1%
- Revenue CAGR, 3YFY2025, the latest fiscal year in the company's growth history.
- -5.1%
- Net profit growth, 1YFY2025, the latest fiscal year in the company's growth history.
- 983.4%
- Free cash flowFY2025, the latest fiscal year in the company's growth history.
- -$91.7M
Solvency
- Current ratio
- 1.58
- Debt / Equity
- 2.46
- Debt / Assets
- 0.44
- CFO / Net profit
- -0.06
- Cash / Market cap
- 13.1%
Where the revenue went
FY2025 ended in a loss, so the lines are listed rather than drawn as a flow.
| Line | FY2025 |
|---|---|
| Revenue | $1.5B |
| Cost of revenue | $1.3B |
| Gross profit | $118.8M |
| Operating expenses | $107.5M |
| Selling, general and administrative | $83.9M |
| Operating income | $11.3M |
| Interest and other | -$106.3M |
| Pretax income | -$95.0M |
| Tax and other | $327.5M |
| Net income | -$422.5M |
Revenue and net profit
Revenue fell 10.1% in FY2025; net profit is the dashed line.
| Date | Revenue | Net profit |
|---|---|---|
| FY2022 | $1.7B | -$14.9M |
| FY2023 | $1.6B | -$101.8M |
| FY2024 | $1.6B | -$39.0M |
| FY2025 | $1.5B | -$422.5M |
Cash flows
FY2025: $23.9M from operations, -$91.7M free after investment (dashed).
| Date | Operating cash flow | Free cash flow |
|---|---|---|
| FY2022 | $68.8M | -$69.4M |
| FY2023 | $136.3M | $8.6M |
| FY2024 | $203.6M | $95.7M |
| FY2025 | $23.9M | -$91.7M |
Growth
Latest fiscal year 2025: each figure with its change over the year before.
- Revenue
- $1.5B-10.1%1Y
- EBITDA
- $136.9M-21.2%1Y
- Net profit
- -$422.5M
- Cash from operations
- $23.9M-88.3%1Y
- Free cash flow
- -$91.7M-195.8%1Y
- Revenue CAGR, 3Y
- -5.1%
| Year | Revenue | EBITDA | Net profit | FCF | ROE | Revenue growth 1Y | Net profit growth 1Y |
|---|---|---|---|---|---|---|---|
| FY2025 | $1.5B | $136.9M | -$422.5M | -$91.7M | -133.5% | -10.1% | +983.4% |
Monthly returns
Month-by-month returns of RYAM across the years, with the seasonal pattern.
Balance sheet
What the company owns and owes at the end of FY2025.
| Line | FY2025 |
|---|---|
| Assets | $1.8B |
| Current assets | $568.4M |
| Non-current assets | $1.2B |
| Liabilities | $1.4B |
| Current liabilities | $360.4M |
| Non-current liabilities | $1.1B |
| Equity | $327.9M |
| Paid-in capital | $427.8M |
| Retained earnings | -$88.9M |
| Minority interest | $11.4M |
Market cap against peers
8 peers: same sector, nearest by size.
Peers map
Basic Materials companies placed by value, growth and quality; RYAM highlighted.
P/E against peers
Most of this group is loss-making, so EV / Sales is compared for the companies without a P/E.
Not shown (no positive earnings and no EV / Sales): Contango Silver & Gold Inc.
Peer comparison
Same-sector peers by market cap, with the median.
| Company | Market cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|
| Rayonier Advanced Materials Inc.RYAMthis company | $576.6M | -1.4x | 1.8x | -133.5% | 9.4x |
| AdvanSix Inc.ASIX | $594.7M | 12.1x | 0.7x | 6.0% | 6.7x |
| Idaho Strategic Resources, Inc.IDR | $583.4M | 34.9x | 5.4x | 15.5% | 29.7x |
| Contango Silver & Gold Inc.CTGO | $575.7M | -16.0x | 22.9x | -143.8% | -19.4x |
| Intrepid Potash, Inc.IPI | $499.4M | 44.7x | 1.0x | 2.3% | 8.1x |
| Lifezone Metals LimitedLZM | $464.3M | -34.1x | 6.3x | -18.5% | -200.4x |
| Gevo, Inc.GEVO | $430.8M | -12.7x | 0.9x | -7.3% | 42.1x |
| Mativ Holdings, Inc.MATV | $423.3M | -1.3x | 0.8x | -67.7% | -5.7x |
| Caledonia Mining Corporation PlcCMCL | $411.4M | 7.4x | 1.6x | 21.3% | 3.2x |
| Peer median | — | 3.1x | 1.3x | -2.5% | 5.0x |
Year-to-date ROI
RYAM since 1 January, against earlier years.
Historical volatility
RYAM's day-to-day swings over 30, 60 and 180 days.
Financial statements
Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.
Consolidated figures in USD, fiscal years, newest first.
Operating margin by fiscal year
| Date | Operating margin |
|---|---|
| FY2022 | 1.6% |
| FY2023 | 0.2% |
| FY2024 | 4.5% |
| FY2025 | 0.8% |
| Line | FY2025 |
|---|---|
| RevenueTotal Revenue | $1.5B |
| Cost of revenueCost Of Revenue | $1.3B |
| Gross profitGross Profit | $118.8M |
| Operating expensesOperating Expense | $107.5M |
| Selling, general and administrativeSelling General And Administration | $83.9M |
| Other operating expensesOther Operating Expenses | $23.6M |
| Total expensesTotal Expenses | $1.5B |
| Operating incomeOperating Income | $11.3M |
| Interest and other | |
| Pretax incomePretax Income | -$95.0M |
| TaxTax Provision | $323.3M |
| Net incomeNet Income | -$422.5M |
| Per share | |
| Supplementary |
| Line | FY2025 |
|---|---|
| AssetsTotal Assets | $1.8B |
| Current assetsCurrent Assets | $568.4M |
| Non-current assetsTotal Non Current Assets | $1.2B |
| LiabilitiesTotal Liabilities Net Minority Interest | $1.4B |
| Current liabilitiesCurrent Liabilities | $360.4M |
| Non-current liabilitiesTotal Non Current Liabilities Net Minority Interest | $1.1B |
| EquityTotal Equity Gross Minority Interest | $327.9M |
| Supplementary |
| Line | FY2025 |
|---|---|
| Operating cash flowOperating Cash Flow | $23.9M |
| Cash from continuing operationsCash Flow From Continuing Operating Activities | $23.9M |
| Net income, continuing operationsNet Income From Continuing Operations | -$423.2M |
| Depreciation and amortisationDepreciation And Amortization | $134.0M |
| Depreciation, amortisation and depletionDepreciation Amortization Depletion | $134.0M |
| Stock-based compensationStock Based Compensation | $5.5M |
| Deferred taxDeferred Tax | $321.9M |
| Deferred income taxDeferred Income Tax | $321.9M |
| Operating gains and lossesOperating Gains Losses | $11.2M |
| Gain loss on sale of PP&EGain Loss On Sale Of PPE | $890.0k |
| Unrealized gain loss on investment securitiesUnrealized Gain Loss On Investment Securities | — |
| Net foreign currency exchange gain lossNet Foreign Currency Exchange Gain Loss | $4.0M |
| Earnings losses from equity investmentsEarnings Losses From Equity Investments | $2.0M |
| Asset impairmentAsset Impairment Charge | $0.00 |
| Pension and employee benefit expensePension And Employee Benefit Expense | $4.3M |
| Change in working capitalChange In Working Capital | -$30.6M |
| Other non-cash itemsOther Non Cash Items | $5.1M |
| Cash from discontinued operating activitiesCash From Discontinued Operating Activities | — |
| Investing cash flowInvesting Cash Flow | -$114.1M |
| Cash from continuing investingCash Flow From Continuing Investing Activities | -$114.1M |
| Capital expenditureCapital Expenditure | -$115.6M |
| Capital expenditure (reported)Capital Expenditure Reported | -$115.6M |
| AcquisitionsPurchase Of Business | -$2.0M |
| Net acquisitions and disposalsNet Business Purchase And Sale | -$2.0M |
| Other investing changesNet Other Investing Changes | $3.5M |
| Cash from discontinued investing activitiesCash From Discontinued Investing Activities | $0.00 |
| Financing cash flowFinancing Cash Flow | $30.1M |
| Cash from continuing financingCash Flow From Continuing Financing Activities | $30.1M |
| Debt issuedIssuance Of Debt | $547.4M |
| Debt repaidRepayment Of Debt | -$512.1M |
| Net debt issuedNet Issuance Payments Of Debt | $33.3M |
| Short-term debt issuedShort Term Debt Issuance | — |
| Short-term debt repaidShort Term Debt Payments | — |
| Net short-term debt issuedNet Short Term Debt Issuance | -$2.0M |
| Long-term debt issuedLong Term Debt Issuance | $547.4M |
| Long-term debt repaidLong Term Debt Payments | -$512.1M |
| Net long-term debt issuedNet Long Term Debt Issuance | $35.3M |
| Net common stock issuedNet Common Stock Issuance | -$3.0M |
| Common stock repurchasedCommon Stock Payments | -$3.0M |
| Share buybacksRepurchase Of Capital Stock | -$3.0M |
| Dividends paidCash Dividends Paid | — |
| Common dividends paidCommon Stock Dividend Paid | — |
| Preferred stock dividend paidPreferred Stock Dividend Paid | — |
| Other financing chargesNet Other Financing Charges | -$200.0k |
| Change in cashChanges In Cash | -$60.1M |
| Effect of exchange ratesEffect Of Exchange Rate Changes | 1,030.0% |
| Cash at the start of the yearBeginning Cash Position | $125.2M |
| Cash at the end of the yearEnd Cash Position | $75.4M |
| Free cash flowFree Cash Flow | -$91.7M |
| Supplemental |
Learn while you research
Academy chapters picked for Rayonier Advanced Materials Inc. and the metrics on this page.
- 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
- 02 Leverage RatiosDebt/Equity of 2.46 is elevated, understand what that means for solvency.6 min read
- 03 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
- 04 Business Cycles & StocksThese cyclical sectors win and lose in different macro phases.6 min read
- 05 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
- 06 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read